|
1
|
Chinese Society of Lymphoma, Chinese
Anti-cancer Association, Chinese Society of Hematology and Chinese
Medical Association, . Chinese guidelines for diagnosis and
treatment of follicular lymphoma (2020). Zhonghua Xue Ye Xue Za
Zhi. 41:537–44. 2020.(In Chinese). PubMed/NCBI
|
|
2
|
Bachy E, Seymour JF, Feugier P, Offner F,
López-Guillermo A, Belada D, Xerri L, Catalano JV, Brice P,
Lemonnier F, et al: Sustained progression-free survival benefit of
rituximab maintenance in patients with follicular lymphoma:
Long-term results of the PRIMA study. J Clin Oncol. 37:2815–2824.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Casulo C, Byrtek M, Dawson KL, Zhou X,
Farber CM, Flowers CR, Hainsworth JD, Maurer MJ, Cerhan JR, Link
BK, et al: Early relapse of follicular lymphoma after rituximab
plus cyclophosphamide, doxorubicin, vincristine, and prednisone
defines patients at high risk for death: An analysis from the
national lymphocare study. J Clin Oncol. 33:2516–2522. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zha J, Fan L, Yi S, Yu H, Zheng Z, Xu W,
Deng M, Lin Z, Li Z, Ping L, et al: Clinical features and outcomes
of 1845 patients with follicular lymphoma: A real-world multicenter
experience in China. J Hematol Oncol. 14:1312021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Silva A, Bassim S, Sarkozy C, Mottok A,
Lackraj T, Jurinovic V, Brodtkorb M, Lingjaerde OC, Sehn LH,
Gascoyne RD, et al: Convergence of risk prediction models in
follicular lymphoma. Haematologica. 104:e252–e255. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Roschewski M, Staudt LM and Wilson WH:
Dynamic monitoring of circulating tumor DNA in non-Hodgkin
lymphoma. Blood. 127:3127–3132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Laurent C, Charmpi K, Gravelle P, Tosolini
M, Franchet C, Ysebaert L, Brousset P, Bidaut A, Ycart B and
Fournié JJ: Several immune escape patterns in non-Hodgkin's
lymphomas. Oncoimmunology. 4:e10265302015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gopalakrishnan V, Helmink BA, Spencer CN,
Reuben A and Wargo JA: The influence of the gut microbiome on
cancer, immunity, and cancer immunotherapy. Cancer Cell.
33:570–580. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Honda K and Littman DR: The microbiota in
adaptive immune homeostasis and disease. Nature. 535:75–84. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schluter J, Peled JU, Taylor BP, Markey
KA, Smith M, Taur Y, Niehus R, Staffas A, Dai A, Fontana E, et al:
The gut microbiota is associated with immune cell dynamics in
humans. Nature. 588:303–307. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Okumura S, Konishi Y, Narukawa M, Sugiura
Y, Yoshimoto S, Arai Y, Sato S, Yoshida Y, Tsuji S, Uemura K, et
al: Gut bacteria identified in colorectal cancer patients promote
tumourigenesis via butyrate secretion. Nat Commun. 12:56742021.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Davar D, Dzutsev AK, McCulloch JA,
Rodrigues RR, Chauvin JM, Morrison RM, Deblasio RN, Menna C, Ding
Q, Pagliano O, et al: Fecal microbiota transplant overcomes
resistance to anti-PD-1 therapy in melanoma patients. Science.
371:595–602. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Q, Ma C, Duan Y, Heinrich B, Rosato
U, Diggs LP, Ma L, Roy S, Fu Q, Brown ZJ, et al: Gut microbiome
directs hepatocytes to recruit MDSCs and promote
cholangiocarcinoma. Cancer Discov. 11:1248–1267. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Matson V, Fessler J, Bao R, Chongsuwat T,
Zha Y, Alegre ML, Luke JJ and Gajewski TF: The commensal microbiome
is associated with anti-PD-1 efficacy in metastatic melanoma
patients. Science. 359:104–108. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Viaud S, Saccheri F, Mignot G, Yamazaki T,
Daillère R, Hannani D, Enot DP, Pfirschke C, Engblom C, Pittet MJ,
et al: The intestinal microbiota modulates the anticancer immune
effects of cyclophosphamide. Science. 342:971–976. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Peled JU, Gomes ALC, Devlin SM, Littmann
ER, Taur Y, Sung AD, Weber D, Hashimoto D, Slingerland AE,
Slingerland JB, et al: Microbiota as predictor of mortality in
allogeneic hematopoietic-cell transplantation. N Engl J Med.
382:822–834. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yuan L, Wang W, Zhang W, Zhang Y, Wei C,
Li J and Zhou D: Gut microbiota in untreated diffuse large B cell
lymphoma patients. Front Microbiol. 12:6463612021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Diefenbach CS, Peters BA, Li H, Raphael B,
Moskovits T, Hymes K, Schluter J, Chen J, Bennani NN, Witzig TE and
Ahn J: Microbial dysbiosis is associated with aggressive histology
and adverse clinical outcome in B-cell non-Hodgkin lymphoma. Blood
Adv. 5:1194–1198. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yoon SE, Kang W, Choi S, Park Y, Chalita
M, Kim H, Lee JH, Hyun DW, Ryu KJ, Sung H, et al: The influence of
microbial dysbiosis on immunochemotherapy-related efficacy and
safety in diffuse large B-cell lymphoma. Blood. 141:2224–2238.
2023.PubMed/NCBI
|
|
20
|
Zeze K, Hirano A, Torisu T, Esaki M,
Shibata H, Moriyama T, Umeno J, Fujioka S, Okamoto Y, Fuyuno Y, et
al: Mucosal dysbiosis in patients with gastrointestinal follicular
lymphoma. Hematol Oncol. 38:181–188. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jakobsson HE, Jernberg C, Andersson AF,
Sjölund-Karlsson M, Jansson JK and Engstrand L: Short-term
antibiotic treatment has differing long-term impacts on the human
throat and gut microbiome. PLoS One. 5:e98362010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rashidi A, Ebadi M, Rehman TU, Elhusseini
H, Nalluri H, Kaiser T, Holtan SG, Khoruts A, Weisdorf DJ and
Staley C: Gut microbiota response to antibiotics is personalized
and depends on baseline microbiota. Microbiome. 9:2112021.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Carbone PP, Kaplan HS, Musshoff K,
Smithers DW and Tubiana M: Report of the committee on Hodgkin's
disease staging classification. Cancer Res. 31:1860–1861.
1971.PubMed/NCBI
|
|
24
|
Solal-Céligny P, Roy P, Colombat P, White
J, Armitage JO, Arranz-Saez R, Au WY, Bellei M, Brice P, Caballero
D, et al: Follicular lymphoma international prognostic index.
Blood. 104:1258–1265. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Alaggio R, Amador C, Anagnostopoulos I,
Attygalle AD, Araujo IBO, Berti E, Bhagat G, Borges AM, Boyer D,
Calaminici M, et al: The 5th edition of the World Health
Organization classification of haematolymphoid tumours: Lymphoid
neoplasms. Leukemia. 36:1720–1748. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Brice P, Bastion Y, Lepage E, Brousse N,
Haïoun C, Moreau P, Straetmans N, Tilly H, Tabah I and
Solal-Céligny P: Comparison in low-tumor-burden follicular
lymphomas between an initial no-treatment policy, prednimustine, or
interferon alfa: A randomized study from the groupe d'etude des
lymphomes folliculaires. groupe d'etude des lymphomes de l'adulte.
J Clin Oncol. 15:1110–1117. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Caporaso JG, Lauber CL, Walters WA,
Berg-Lyons D, Lozupone CA, Turnbaugh PJ, Fierer N and Knight R:
Global patterns of 16S rRNA diversity at a depth of millions of
sequences per sample. Proc Natl Acad Sci USA. 108 (Suppl
1):S4516–S4522. 2011. View Article : Google Scholar
|
|
28
|
Cole JR, Wang Q, Fish JA, Chai B,
McGarrell DM, Sun Y, Brown CT, Porras-Alfaro A, Kuske CR and Tiedje
JM: Ribosomal database project: Data and tools for high throughput
rRNA analysis. Nucleic Acids Res. 42:(Database Issue). D633–D642.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Caporaso JG, Kuczynski J, Stombaugh J,
Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich
JK, Gordon JI, et al: QIIME allows analysis of high-throughput
community sequencing data. Nat Methods. 7:335–336. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
R Core Team, . R: A language and
environment for statistical computing. R Foundation for Statistical
Computing; Vienna, Austria: 2022, URL. https://www.R-project.org/
|
|
31
|
Schloss PD, Westcott SL, Ryabin T, Hall
JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH,
Robinson CJ, et al: Introducing mothur: Open-source,
platform-independent, community-supported software for describing
and comparing microbial communities. Appl Environ Microbiol.
75:7537–7541. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pilgrim M and Willison S: Dive into python
3.2. Springer; 2009
|
|
33
|
Douglas GM, Maffei VJ, Zaneveld JR, Yurgel
SN, Brown JR, Taylor CM, Huttenhower C and Langille MGI: PICRUSt2
for prediction of metagenome functions. Nat Biotechnol. 38:685–688.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Johansson ME, Jakobsson HE, Holmén-Larsson
J, Schütte A, Ermund A, Rodríguez-Piñeiro AM, Arike L, Wising C,
Svensson F, Bäckhed F and Hansson GC: Normalization of host
intestinal mucus layers requires long-term microbial colonization.
Cell Host Microbe. 18:582–592. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gaboriau-Routhiau V, Rakotobe S, Lécuyer
E, Mulder I, Lan A, Bridonneau C, Rochet V, Pisi A, De Paepe M,
Brandi G, et al: The key role of segmented filamentous bacteria in
the coordinated maturation of gut helper T cell responses.
Immunity. 31:677–689. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fattizzo B, Cavallaro F, Folino F and
Barcellini W: Recent insights into the role of the microbiome in
malignant and benign hematologic diseases. Crit Rev Oncol Hematol.
160:1032892021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yamamoto ML and Schiestl RH: Intestinal
microbiome and lymphoma development. Cancer J. 20:190–194. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xie J, Li LF, Dai TY, Qi X, Wang Y, Zheng
TZ, Gao XY, Zhang YJ, Ai Y, Ma L, et al: Short-chain fatty acids
produced by Ruminococcaceae mediate α-linolenic acid promote
intestinal stem cells proliferation. Mol Nutr Food Res.
66:e21004082022. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hall AB, Yassour M, Sauk J, Garner A,
Jiang X, Arthur T, Lagoudas GK, Vatanen T, Fornelos N, Wilson R, et
al: A novel Ruminococcus gnavus clade enriched in
inflammatory bowel disease patients. Genome Med. 9:1032017.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Breban M, Tap J, Leboime A, Said-Nahal R,
Langella P, Chiocchia G, Furet JP and Sokol H: Faecal microbiota
study reveals specific dysbiosis in spondyloarthritis. Ann Rheum
Dis. 76:1614–1622. 2017. View Article : Google Scholar : PubMed/NCBI
|
